Novo Nordisk A/S’s latest experimental obesity drug helped patients lose as much as 24.3% of their weight in a small study, showing its potential as a next-generation treatment in the hyper-competitive market.
www.bloomberg.com
#Novos #Latest #Obesity #Drug #Shows #Weight #Loss #Small #Trial
Congressional Republicans who are pro-Ukraine and anti-Russia are mustering more courage to help the president correct course. www.bloomberg.com #Republicans #Ready #Maximum…
Comprehensive cross-platform coverage of the U.S. market close on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Alix Steel,…
The risk that’s on everyone’s mind. www.bloomberg.com #Talking #Stagflation Related reading:Chaos Rocks Bolivia After Bank Voids $62 Million That Fell…
